Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

Browsing publications by Rachel Cant

Newcastle AuthorsTitleYearFull text
Dr Lisa Shaw
Dr Nawaraj Bhattarai
Rachel Cant
Professor Gary Ford
Emeritus Professor Roger Francis
et al.
An extended stroke rehabilitation service for people who have had a stroke: the EXTRAS RCT2020
Dr Steven O'Reilly
Dr Marzena Ciechomska
Rachel Cant
Professor Jaap van Laar
Interleukin-6 (IL-6) Trans Signaling Drives a STAT3-dependent Pathway That Leads to Hyperactive Transforming Growth Factor-beta (TGF-beta) Signaling Promoting SMAD3 Activation and Fibrosis via Gremlin Protein2014
Dr Steven O'Reilly
Rachel Cant
Dr Marzena Ciechomska
Professor Fiona Oakley
Professor Sophie Hambleton
et al.
Serum Amyloid A (SAA) induces IL-6 in dermal fibroblasts via TLR2, IRAK4 and NF-κB2014
Dr Steven O'Reilly
Rachel Cant
Dr Marzena Ciechomska
James Finnigan
Professor Fiona Oakley
et al.
Serum amyloid A induces interleukin-6 in dermal fibroblasts via Toll-like receptor 2, interleukin-1 receptor-associated kinase 4 and nuclear factor-kappa B2014
Dr Steven O'Reilly
Rachel Cant
Dr Marzena Ciechomska
Professor Jaap van Laar
Acute Serum Amyloid A (A-SSA) Induces TIMP-1 in Dermal Fibroblasts that is Mediated Via a TLR-Dependent and Formyl Receptor-Independent Pathway2013
Dr Steven O'Reilly
Rachel Cant
Dr Marzena Ciechomska
Professor Jaap Van Laar
Interleukin-6: a new therapeutic target in systemic sclerosis?2013
Dr Marzena Ciechomska
Rachel Cant
James Finnigan
Professor Jaap Van Laar
Dr Steven O'Reilly
Role of toll-like receptors in systemic sclerosis2013